Australia markets closed

Organon & Co. (OGN)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
29.94-0.38 (-1.25%)
At close: 04:04PM EST
30.00 +0.06 (+0.20%)
Pre-market: 06:28AM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
6,292,000
6,304,000
8,096,000
7,777,000
Cost of revenue
2,299,000
2,382,000
3,347,000
2,274,000
Gross profit
3,993,000
3,922,000
4,749,000
5,503,000
Operating expenses
Research development
543,000
443,000
304,000
220,000
Selling general and administrative
1,716,000
1,668,000
1,666,000
1,443,000
Total operating expenses
2,259,000
2,111,000
1,970,000
1,663,000
Operating income or loss
1,734,000
1,811,000
2,779,000
3,840,000
Interest expense
401,000
258,000
-
0
Total other income/expenses net
-86,000
-24,000
-99,000
-144,000
Income before tax
1,247,000
1,529,000
2,680,000
3,696,000
Income tax expense
236,000
178,000
520,000
390,000
Income from continuing operations
1,011,000
1,351,000
2,160,000
3,306,000
Net income
1,011,000
1,351,000
2,160,000
3,218,000
Net income available to common shareholders
1,011,000
1,351,000
2,160,000
3,218,000
Basic EPS
-
5.33
8.53
12.71
Diluted EPS
-
5.31
8.53
12.71
Basic average shares
-
253,538
253,130
253,130
Diluted average shares
-
254,193
253,130
253,130
EBITDA
-
1,982,000
2,936,000
4,029,000